Geron Corporation (NASDAQ:GERN) saw an upside of 0.73% on Friday at $1.38 after adding $0.01. The 5-day average trading volume is 1,053,047 shares of the company’s common stock. It has gained $1.4700 in the past week and touched a new high 1 time within the past 5 days. An average of 1,746,277 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,806,447.
GERN’s 1-month performance is -5.52% or -$0.0900 on its low of $1.3050 reached on 09/15/21. The company’s shares have touched a 52-week low of $1.20 and high of $2.36, with the stock’s rally to the 52-week high happening on 02/03/21. YTD, GERN has lost -13.84% or -$0.2200 and has reached a new high 11 times. However, the current price is down -41.40%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Geron Corporation (GERN) has a trailing price-to-earnings (P/E) ratio of 33.74 for the broader industry and 32.32 for the sector, meaning that investors are optimistic about the stock’s future prospects. GERN stock has a beta of 1.09. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1162.24 while the price-to-book (PB) in the most recent quarter is 2.54.
Geron Corporation’s quick ratio for the period ended June 29 was 5.50, with the current ratio over the same period at 5.50 meaning that GERN stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.20, while the total debt to equity was 0.20The trailing 12-month EBITDA margin is -30030.83%. The firm’s gross profit as reported stood at $77.17 million against revenue of $0.25 million.
The effectiveness of a company’s management is also important for investors when it comes to determining the potential profitability of the investment. Geron Corporation’s return on assets over the past 12 months stands at -37.80%. Return on investment over the past year is -32.70%, while its return on equity (ROE) trailing 12 months is -49.10%. In comparison, the average ROE for the broader industry over the past year is -36.91.
For the quarterly period ending June 29 this year, Geron Corporation’s cash and short-term investments amounted to $140.96 million against total debt of $39.84 million. Net income and sales went down compared to those figures reported in the previous quarter. Net income grew 63.64% to $0.11 million, while revenue of $0.14 million was -27.27% off the previous quarter. Analysts expected GERN to announce -$0.09 per share in earnings in its latest quarter, but it posted -$0.09, representing a 0.00% surprise. EBITDA for the quarter stood at more than -$28.15 million. GERN stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 75.97 million, with total debt at $39.84 million. Shareholders hold equity totaling $320.6 million
Let’s look briefly at Geron Corporation (GERN) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 30 September was 46.11% to suggest the stock is trending Neutral, with historical volatility in this time period at 50.75%.
The stock’s 5-day moving average is $1.3960, reflecting a unch or $unch change from its current price. GERN is currently trading -8.67% above its 20-day SMA, -1.44% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by +6.20% and -18.45% respectively.
Stochastic %K and %D was 39.41% and 49.33% and the average true range (ATR) pointed at 0.0704. The RSI (14) points at 48.53%, while the 14-day stochastic is at 38.24% with the period’s ATR at 0.0709. The stock’s 9-day MACD Oscillator is pointing at -0.0267 and -0.0167 on the 14-day charts.
Analysts offering their rating for GERN stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate GERN as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 4 have offered a “buy” rating.
What is GERN’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $3.00 and a high of $4.00, with their median price target at $3.50. Looking at these predictions, the average price target given by analysts is for Geron Corporation (GERN) stock is $3.50.